Briefly Bio raises €1.1M Pre-Seed round
17 July 2024· London, United Kingdom· biotechnology, health, ai, industrial_software, b2b, pure_software
The investment will help Briefly Bio further commercialize its software, aiming to enhance the reproducibility of biological science in both industry and academia.
Investors
LeadCompound
Also participating
NP Hardangel investorsTiny VC
About Briefly Bio
Key People
Harry RickerbyCEO and Co-founder
Dr. Katya PutintsevaCo-founder
Staffan PiledahlCo-founder
Stage
Pre-Seed
Headquarters
London, United Kingdom
Founded
2022
Team Size
1–5
Sectors
biotechnologyhealthaiindustrial_softwareb2bpure_software
Source: https://vestbee.com/news/london-based-biotech-briefly-bio-secures-1-2m-in-a-pre-seed-round/